PharmiWeb.com - Global Pharma News & Resources
21-Jan-2021

HumanOptics AG: Request by the main shareholder to execute a merger squeeze-out

HumanOptics AG / Key word(s): Squeeze Out
HumanOptics AG: Request by the main shareholder to execute a merger squeeze-out

21-Jan-2021 / 16:10 CET/CEST
Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


Publication of inside information pursuant to Article 17 of Regulation (EU) No. 596/2014

Request by the main shareholder to execute a merger squeeze-out

Erlangen, 21 January 2021 - Today, the Management Board of HumanOptics AG (ISIN DE000A1MMCR6) has received the formal request of HumanOptics Holding AG, with its registered office in Frankfurt am Main, ("Holding") pursuant to section 62(1) and (5) sentence 1 of the German Transformation Act (Umwandlungsgesetz - UmwG) in conjunction with sections 327a et seqq. of the German Stock Corporation Act (Aktiengesetz - AktG), to execute the procedure for the transfer of the shares of the minority shareholders of HumanOptics AG in exchange for an appropriate cash compensation in connection with a merger of HumanOptics AG into the Holding by absorption (so-called merger squeeze-out) and for this purpose to have the general meeting of HumanOptics AG pass a resolution on the transfer of the shares of the minority shareholders of HumanOptics AG within three months upon conclusion of the merger agreement. The Holding intends to simplify its shareholding structure with the group merger, in connection with which the minority shareholders of HumanOptics AG are to be excluded. The merger agreement shall contain a statement pursuant to section 62(5) sentence 2 German Transformation Act that a squeeze-out of the minority shareholders of HumanOptics AG as the transferring entity shall occur in the context of the merger. The Holding will communicate the amount of the appropriate cash compensation, which the Holding will pay to the minority shareholders of HumanOptics AG in return for the transfer of the shares, at a later date. The Holding will submit a written report to the general meeting of HumanOptics AG, which will set out the conditions for the transfer of the shares of the minority shareholders of HumanOptics AG and explain the appropriateness of the cash compensation.

The Holding holds, according to its own information, 3,249,870 shares in HumanOptics AG, corresponding to a stake of approximately 93.2 percent in the share capital of HumanOptics AG. The Holding is therefore the main shareholder within the meaning of section 62(1) and (5) sentence 1 German Transformation Act.

The effectiveness of the merger squeeze-out is still subject to the resolution by the General Meeting of HumanOptics AG and the registration of the transfer resolution and the merger in the commercial registers at the seats of HumanOptics AG resp. the Holding.


End of ad hoc announcement



Contact:

HumanOptics AG
Investor Relations
Spardorfer Str. 150
91054 Erlangen
Germany
Phone: +49 (0) 9131 50665-0
E-Mail: IR@humanoptics.com


21-Jan-2021 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de


Language: English
Company: HumanOptics AG
Spardorfer Str. 150
91054 Erlangen
Germany
Phone: +49 (0)9131 - 50665-60
Fax: +49 (0)9131 - 50665-93
E-mail: mail@humanoptics.com
Internet: www.humanoptics.de
ISIN: DE000A1MMCR6, DE000A255FK8
WKN: A1MMCR
Listed: Regulated Unofficial Market in Berlin, Dusseldorf, Frankfurt (Basic Board), Stuttgart
EQS News ID: 1162359

 
End of Announcement DGAP News Service

Editor Details

Last Updated: 21-Jan-2021